Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

유방암 검진 권고안 개정안

Full metadata record
DC Field Value Language
dc.contributor.author이은혜-
dc.contributor.author박보영-
dc.contributor.author김남순-
dc.contributor.author서현주-
dc.contributor.author고경란-
dc.contributor.author민준원-
dc.contributor.author신명희-
dc.contributor.author이기헌-
dc.contributor.author이시연-
dc.contributor.author정준-
dc.date.accessioned2022-07-15T22:49:19Z-
dc.date.available2022-07-15T22:49:19Z-
dc.date.issued2015-05-
dc.identifier.issn1975-8456-
dc.identifier.issn2093-5951-
dc.identifier.urihttps://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/157208-
dc.description.abstractBreast cancer is the second most common malignancy among Korean women. The 2002 National Cancer Center screening guideline breast cancer was revised via an evidence-based approach to provide medical personnel with a standard protocol of screening breast cancer. There is moderate-level evidence that biennial screening mammography in asymptomatic women aged 40 to 69 reduces breast cancer mortality, while low-level evidence suggests that screening mammography in women 70 years or older does not reduce breast cancer mortality. The committee concluded that the current evidence is insufficient to assess the benefits and harms of eithe ultrasonography or clinical breast examination as screening modalities for breast cancer. Future researches about the benefits and harms of the National Breast Cancer Screening Program in Korea are strongly required because the characteristics of breast cancer in Korea are different from those in the West, especially regarding dense breast. In conclusion, the committee recommends biennial screening mammography in asymptomatic women aged 40 to 69 years (grade B recommendation). The committee recommends selective screening mammography in women 70 years or older according to individual risk and preference (grade C recommendation). The committee neither recommends nor opposes ultrasonography and clinical breast examination as screening modalities (grade I recommendation). Symptomatic and high-risk women, however, should be offered complementary measures including ultrasonography and clinical breast examination under clinical supervision. © Korean Medical Association.-
dc.format.extent12-
dc.language한국어-
dc.language.isoKOR-
dc.publisher대한의사협회-
dc.title유방암 검진 권고안 개정안-
dc.title.alternativeThe Korean guideline for breast cancer screening-
dc.typeArticle-
dc.publisher.location대한민국-
dc.identifier.doi10.5124/jkma.2015.58.5.408-
dc.identifier.scopusid2-s2.0-84982103424-
dc.identifier.bibliographicCitationJournal of the Korean Medical Association, v.58, no.5, pp 408 - 419-
dc.citation.titleJournal of the Korean Medical Association-
dc.citation.volume58-
dc.citation.number5-
dc.citation.startPage408-
dc.citation.endPage419-
dc.type.docType정기학술지(Article(Perspective Article포함))-
dc.identifier.kciidART001990899-
dc.description.isOpenAccessN-
dc.description.journalRegisteredClassscopus-
dc.description.journalRegisteredClasskci-
dc.subject.keywordAuthorBreast neoplasms-
dc.subject.keywordAuthorGuideline-
dc.subject.keywordAuthorMammography-
dc.subject.keywordAuthorMass screening-
Files in This Item
Appears in
Collections
서울 의과대학 > 서울 예방의학교실 > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Park, Bo Young photo

Park, Bo Young
서울 의과대학 (DEPARTMENT OF PREVENTIVE MEDICINE)
Read more

Altmetrics

Total Views & Downloads

BROWSE